Neuregulin 1-alpha expression in locally advanced breast cancer
2001; Elsevier BV; Volume: 10; Issue: 1 Linguagem: Inglês
10.1054/brst.2000.0182
ISSN1532-3080
AutoresE. Hemanth Raj, Ann Skinner, Urmila Mahji, K. Nirmala, Kodi S. Ravichandran, V. Shanta, Helen C. Hurst, William J. Gullick, Thangarajan Rajkumar,
Tópico(s)Glycosylation and Glycoproteins Research
ResumoThe human Neuregulin 1 (NRG1) gene encodes several alternatively spliced ligands that bind to both c-erbB-3 and c-erbB-4, members of the family of type 1 tyrosine kinase growth factor receptors. Antibodies raised to a synthetic peptide recognize selectively the alpha variant of NRG1. The NRG1-alpha isoforms' expression was studied in 115 locally advanced adenocarcinomas of the breast using immunohistochemistry. Absent or low levels of NRG1-alpha were found to be associated with poorer prognosis compared to tumours that had moderate to high levels of the protein.
Referência(s)